2014

Kloke B, Mahr A, Jabulowsky RA, Kutscher S, Rae R, Britten CM: Cancer immunotherapy achieves breakthrough status: 12th annual meeting of the association for cancer immunotherapy (CIMT), Mainz, Germany, May 6-8, 2014. Cancer immunology, immunotherapy: CII 2015, 64:923-930.
DOI; PubMed

Diken M, Boegel S, Grunwitz C, Kranz LM, Reuter K, van de Roemer, Niels, Vascotto F, Vormehr M, Kreiter S: CIMT 2014: Next waves in cancer immunotherapy–report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany. Human vaccines & immunotherapeutics 2014, 10:3090-3100.
DOI; PubMed

Boegel S, Löwer M, Bukur T, Sahin U, Castle JC: A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines. Oncoimmunology 2014, 3:e954893.
DOI; PubMed

Hadrup SR, Maurer D, Laske K, Frøsig TM, Andersen SR, Britten CM, van der Burg, Sjoerd H, Walter S, Gouttefangeas C: Cryopreservation of MHC multimers: Recommendations for quality assurance in detection of antigen specific T cells. Cytometry. Part A: the journal of the International Society for Analytical Cytology 2015, 87:37-48.
DOI; PubMed

Boisguérin V, Castle JC, Loewer M, Diekmann J, Mueller F, Britten CM, Kreiter S, Türeci Ö, Sahin U: Translation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside. Br J Cancer 2014, 111:1469-1475.
DOI; PubMed

Muhammad K, Alrefai H, Marienfeld R, Pham, Duong Anh Thuy, Murti K, Patra AK, Avots A, Bukur V, Sahin U, Kondo E, Klein-Hessling S, Serfling E: NF-κB factors control the induction of NFATc1 in B lymphocytes. European journal of immunology 2014, 44:3392-3402.
DOI; PubMed

Kowalska J, Wypijewska del Nogal, Anna, Darzynkiewicz ZM, Buck J, Nicola C, Kuhn AN, Lukaszewicz M, Zuberek J, Strenkowska M, Ziemniak M, Maciejczyk M, Bojarska E, Rhoads RE, Darzynkiewicz E, Sahin U, Jemielity J: Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes. Nucleic acids research 2014, 42:10245-10264.
DOI; PubMed

Kuehnle M, Attig S, Britten CM, Schulze-Bergkamen H, Lordick F, Wichert G von, Thuss-Patience P, Stein A, Schuler M, Bassermann F, Sahin U, Türeci O: Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction. Cancer immunology, immunotherapy: CII 2014, 63:1273-1284.
DOI; PubMed

Chudley L, McCann KJ, Coleman A, Cazaly AM, Bidmon N, Britten CM, van der Burg, Sjoerd H, Gouttefangeas C, Jandus C, Laske K, Maurer D, Romero P, Schröder H, Stynenbosch, Linda F M, Walter S, Welters, Marij J P, Ottensmeier CH: Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8(+) T cells with detection by ELISPOT and HLA-multimer staining. Cancer immunology, immunotherapy: CII 2014, 63:1199-1211.
DOI; PubMed

Schumacher T, Bunse L, Pusch S, Sahm F, Wiestler B, Quandt J, Menn O, Osswald M, Oezen I, Ott M, Keil M, Balß J, Rauschenbach K, Grabowska AK, Vogler I, Diekmann J, Trautwein N, Eichmüller SB, Okun J, Stevanović S, Riemer AB, Sahin U, Friese MA, Beckhove P, Deimling A von, Wick W, Platten M: A vaccine targeting mutant IDH1 induces antitumour immunity. Nature 2014, 512:324-327.
DOI; PubMed

White S, Laske K, Welters MJ, Bidmon N, van der Burg, Sjoerd H, Britten CM, Enzor J, Staats J, Weinhold KJ, Gouttefangeas C, Chan C: Managing Multi-center Flow Cytometry Data for Immune Monitoring. Cancer informatics 2014, 13:111-122.
DOI; PubMed

Reuter S, Martin H, Beckert H, Bros M, Montermann E, Belz C, Heinz A, Ohngemach S, Sahin U, Stassen M, Buhl R, Eshkind L, Taube C: The Wnt/β-catenin pathway attenuates experimental allergic airway disease. Journal of immunology (Baltimore, Md.: 1950) 2014, 193:485-495.
PubMed

Janetzki S, Britten CM: The role of the reporting framework MIATA within current efforts to advance immune monitoring. Journal of immunological methods 2014, 409:6-8.
DOI; PubMed

Castle JC, Loewer M, Boegel S, Tadmor AD, Boisguerin V, Graaf J de, Paret C, Diken M, Kreiter S, Türeci Ö, Sahin U: Mutated tumor alleles are expressed according to their DNA frequency. Scientific reports 2014, 4:4743.
DOI; PubMed

Micke P, Mattsson, Johanna Sofia Margareta, Edlund K, Lohr M, Jirström K, Berglund A, Botling J, Rahnenfuehrer J, Marincevic M, Pontén F, Ekman S, Hengstler J, Wöll S, Sahin U, Türeci O: Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer. International journal of cancer. Journal international du cancer 2014, 135:2206-2214.
DOI; PubMed

Schnatbaum K, Schmoldt H, Daneschdar M, Plum LM, Jansong J, Zerweck J, Kühne Y, Masch A, Wenschuh H, Fiedler M, Türeci Ö, Sahin U, Reimer U: Peptide microarrays enable rapid mimotope optimization for pharmacokinetic analysis of the novel therapeutic antibody IMAB362. Biotechnology journal 2014, 9:545-554.
DOI; PubMed

Castle JC, Loewer M, Boegel S, Graaf J de, Bender C, Tadmor AD, Boisguerin V, Bukur T, Sorn P, Paret C, Diken M, Kreiter S, Türeci Ö, Sahin U: Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma. BMC genomics 2014, 15:190.
DOI; PubMed